Northeast Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,104
Closed -$671K 167
2017
Q4
$671K Sell
4,104
-39,579
-91% -$7.1M 0.06% 108
2017
Q3
$8.95M Buy
43,683
+5,613
+15% +$1.31M 0.79% 46
2017
Q2
$9.25M Buy
38,070
+36,225
+1,963% +$8.51M 0.84% 47
2017
Q1
$441K Buy
+1,845
New +$430K 0.04% 121
2015
Q3
Sell
-1,080
Closed -$328K 166
2015
Q2
$328K Sell
1,080
-236
-18% -$70.4K 0.03% 126
2015
Q1
$392K Buy
+1,316
New +$375K 0.04% 126

Other funds holding AGN

Northeast Investment Management's AGN Position: Q1 2018 in Review

Northeast Investment Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 4,104 shares — an estimated $671K sold.

Northeast Investment Management first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $9.25M in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Northeast Investment Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Northeast Investment Management sold 4,104 Allergan plc shares in Q1 2018, an estimated $671K.
  • Northeast Investment Management first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Northeast Investment Management's Allergan plc position peaked at $9.25M in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Northeast Investment Management's 13F filing for Q1 2018, filed 15 May 2018.